New York City, NY -- (SBWIRE) -- 10/04/2013 -- StockMarketIntel.com issues a special report on the following stocks: Biozone Pharmaceuticals Inc(OTCBB:BZNE), Idera Pharmaceuticals Inc (NASDAQ:IDRA) , Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) , Groupon Inc(NASDAQ:GRPN)
Biozone Pharmaceuticals Inc(OTCBB:BZNE) recently declined -5.56%, while trading on 4.83M shares at the price of $0.510. If we look at its trading history of the past 52 weeks, the share price suffered a low of 0.16 and was moved to its maximum level of $3.75.The stock changed hands in a range of $0.49 to $0.58, bringing its market capitalization at about $35.50million. Biozone Pharmaceuticals, Inc., through its subsidiaries, engages in developing and manufacturing over the counter (OTC) drug products, and cosmetic and beauty products on behalf of third parties in the United States and internationally
Has BZNE Found The Bottom and Ready To Move Up? Find Out Here
Idera Pharmaceuticals Inc (NASDAQ:IDRA) added 24.37% recently, while trading on 5.10M shares at the price of $2.45. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.19 and was moved to its maximum level of $2.55.The stock changed hands in a range of $2.00 to $2.55, bringing its market capitalization at about $114.48 million. dera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.
For How Long IDRA Gloss will Attract Investors? Find out via this report
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) recently declined -1.20% and was moving within a range of $4.89-$5.11, its current trading price is $4.94. The stock is moving up till now with a total volume of 7.14M shares, versus an average volume of 5.12M shares. The share price hit its 52-week low of $4.78 and $11.00 was the best price. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases
Will ARNA Get Buyers Even After The Recent Rally? Find Out Here
Groupon Inc(NASDAQ:GRPN) declined -3.99% in its current trading activity, bringing its market capitalization around $7.52 billion. The total number of shares that changed hands during the current session up till now was 33.24M shares, as compared to average trading volume of 20.89M shares. The share price after opening at $11.89 made a high of $12.31 and hovered above $11.28, while its recent trading price was $11.30. Groupon, Inc. operates as a local commerce marketplace that connects merchants to consumers by offering goods and services at a discount in North America and internationally. The company also offers deals on products for which it acts as the merchant of record.
Why Should Investors Buy GRPN After the Recent Fall? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)